Allogeneic Hematopoietic Cell Transplantation and Other Expensive Cellular Therapies: A Miracle for the Few but Off Limits to Many?

[1]  W. Wood,et al.  Inferior Access to Allogeneic Transplant in Disadvantaged Populations: A CIBMTR Analysis. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  M. Bevans,et al.  Caregiver availability and patient access to hematopoietic cell transplantation: social worker perspectives inform practice , 2019, Supportive Care in Cancer.

[3]  G. Abel,et al.  Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  Abdulrahman M El-Sayed,et al.  Ineffective insurance in lower and middle income countries is an obstacle to universal health coverage , 2018, Journal of global health.

[5]  V. Mathews,et al.  First Global Blood & Marrow Transplant [GlobalBMT] Conference in Kathmandu with experiences from Nepal, India, Singapore and Sri Lanka , 2018, Journal of Global Health.

[6]  S. Giralt,et al.  Value-Based Care in Hematopoietic Cell Transplantation and Cellular Therapy: Challenges and Opportunities , 2018, Current Hematologic Malignancy Reports.

[7]  N. Majhail,et al.  Patient-centered care coordination in hematopoietic cell transplantation. , 2017, Blood advances.

[8]  M. Martínez,et al.  Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients , 2017, PloS one.

[9]  K. Ness,et al.  Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study. , 2016, JAMA oncology.

[10]  G. Abel,et al.  Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  David R. Williams,et al.  Understanding associations among race, socioeconomic status, and health: Patterns and prospects. , 2016, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[12]  M. Pasquini,et al.  Haematopoietic cell transplants in Latin America , 2016, Bone Marrow Transplantation.

[13]  N. Khera.  Beyond Biology: Impact of Center- and Country-specific Economic Factors on Outcomes After Hematopoietic Cell Transplantation , 2015, EBioMedicine.

[14]  Michael J. Eckrich,et al.  National Survey of Hematopoietic Cell Transplantation Center Personnel, Infrastructure, and Models of Care Delivery. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  N. Majhail,et al.  Estimating demand and unmet need for allogeneic hematopoietic cell transplantation in the United States using geographic information systems. , 2015, Journal of oncology practice.

[16]  Jean M. Mitchell,et al.  Factors affecting receipt of expensive cancer treatments and mortality: evidence from stem cell transplantation for leukemia and lymphoma. , 2015, Health services research.

[17]  J. Tilburt,et al.  Financial burden in recipients of allogeneic hematopoietic cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[18]  R. Larson,et al.  Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients , 2014, Haematologica.

[19]  H. Deeg,et al.  Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. , 2014, Blood.

[20]  R. Setia,et al.  Cost of Hematopoietic Stem Cell Transplantation in India , 2014, Mediterranean journal of hematology and infectious diseases.

[21]  A. Mills,et al.  Health care systems in low- and middle-income countries. , 2014, The New England journal of medicine.

[22]  K. Kuntz,et al.  Prevalence of hematopoietic cell transplant survivors in the United States. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  H. Valdimarsdottir,et al.  Economic survivorship stress is associated with poor health‐related quality of life among distressed survivors of hematopoietic stem cell transplantation , 2013, Psycho-oncology.

[24]  N. Majhail,et al.  Costs and cost-effectiveness of hematopoietic cell transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[25]  H. Brenner,et al.  Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups , 2012, Haematologica.

[26]  Stephanie J. Lee,et al.  Economics of hematopoietic cell transplantation. , 2012, Blood.

[27]  J. Pidala,et al.  Practice variation in physician referral for allogeneic hematopoietic cell transplantation , 2012, Bone Marrow Transplantation.

[28]  D. Weisdorf,et al.  The National Marrow Donor Program's Symposium on Hematopoietic Cell Transplantation in 2020: a health care resource and infrastructure assessment. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[29]  D. Blazer,et al.  Racial/ethnic variations in substance-related disorders among adolescents in the United States. , 2011, Archives of general psychiatry.

[30]  H. Deeg,et al.  Who is fit for allogeneic transplantation? , 2010, Blood.

[31]  N. Majhail,et al.  Access to hematopoietic cell transplantation in the United States. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[32]  P. Hari,et al.  Access to hematopoietic stem cell transplantation , 2010, Cancer.

[33]  A. Gratwohl,et al.  Hematopoietic stem cell transplantation: a global perspective. , 2010, JAMA.

[34]  H. Jim,et al.  Quality of life after allogeneic hematopoietic cell transplantation. , 2009, Blood.

[35]  J. Beaumont,et al.  Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Ahmedin Jemal,et al.  Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.

[37]  A. Bracey,et al.  Hematopoietic cell transplantation in 2020: summary of year 2 recommendations of the National Marrow Donor Program's System Capacity Initiative. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[38]  N. Daniels.  Health-care needs and distributive justice. , 1981, Philosophy & public affairs.